Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CLDX

Celldex Therapeutics (CLDX)

Celldex Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLDX
DateTimeSourceHeadlineSymbolCompany
15/05/202422:01GlobeNewswire Inc.Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo NodularisNASDAQ:CLDXCelldex Therapeutics Inc
07/05/202406:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLDXCelldex Therapeutics Inc
07/05/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLDXCelldex Therapeutics Inc
07/05/202406:01GlobeNewswire Inc.Celldex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLDXCelldex Therapeutics Inc
17/04/202422:01GlobeNewswire Inc.Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible UrticariaNASDAQ:CLDXCelldex Therapeutics Inc
08/03/202423:00GlobeNewswire Inc.Celldex Therapeutics to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
06/03/202402:30GlobeNewswire Inc.Celldex Therapeutics to Present at TD Cowen’s 44th Annual Health Care ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
06/03/202402:10GlobeNewswire Inc.Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:CLDXCelldex Therapeutics Inc
02/03/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLDXCelldex Therapeutics Inc
02/03/202408:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLDXCelldex Therapeutics Inc
01/03/202413:14GlobeNewswire Inc.Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common StockNASDAQ:CLDXCelldex Therapeutics Inc
29/02/202408:10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLDXCelldex Therapeutics Inc
29/02/202408:01GlobeNewswire Inc.Celldex Therapeutics Announces Proposed Public Offering of Common StockNASDAQ:CLDXCelldex Therapeutics Inc
27/02/202400:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLDXCelldex Therapeutics Inc
26/02/202423:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CLDXCelldex Therapeutics Inc
26/02/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLDXCelldex Therapeutics Inc
26/02/202423:01GlobeNewswire Inc.Celldex Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLDXCelldex Therapeutics Inc
25/02/202406:05GlobeNewswire Inc.Celldex Therapeutics Presents Positive 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous UrticariaNASDAQ:CLDXCelldex Therapeutics Inc
16/02/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLDXCelldex Therapeutics Inc
15/02/202408:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLDXCelldex Therapeutics Inc
15/02/202404:52Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
15/02/202403:48Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
14/02/202423:38Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLDXCelldex Therapeutics Inc
14/02/202401:41Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
09/02/202402:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CLDXCelldex Therapeutics Inc
07/02/202408:01GlobeNewswire Inc.Celldex to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
06/02/202400:01GlobeNewswire Inc.Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024NASDAQ:CLDXCelldex Therapeutics Inc
05/01/202408:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLDXCelldex Therapeutics Inc
28/11/202308:15GlobeNewswire Inc.Celldex Therapeutics to Present at 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CLDXCelldex Therapeutics Inc
21/11/202308:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CLDXCelldex Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CLDX

Your Recent History

Delayed Upgrade Clock